BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35117798)

  • 1. Incidence, treatment, and survival analysis in esophageal neuroendocrine carcinoma population.
    Li Z; Hu J; Chen P; Zeng Z
    Transl Cancer Res; 2020 Jul; 9(7):4317-4329. PubMed ID: 35117798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinicopathological features and survival analysis between esophageal neuroendocrine carcinoma and esophageal squamous cell carcinoma based on the SEER database, alongside nomogram analysis for esophageal neuroendocrine carcinoma.
    Lin Z; Chen YY; Liu CH; Panzuto F; Ramirez RA; Lang M; Kim H; Ding ZY
    J Gastrointest Oncol; 2023 Dec; 14(6):2309-2323. PubMed ID: 38196527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics, prognostic factors, and survival trends in esophageal neuroendocrine carcinomas: A population-based study.
    Chen C; Hu H; Zheng Z; Yang Y; Chen W; Qiao X; Li P; Zhang S
    Cancer Med; 2022 Dec; 11(24):4935-4945. PubMed ID: 35596661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nationwide survey of neuroendocrine carcinoma of the esophagus: a multicenter study conducted among institutions accredited by the Japan Esophageal Society.
    Sohda M; Kuwano H; Saeki H; Miyazaki T; Sakai M; Kakeji Y; Toh Y; Doki Y; Matsubara H
    J Gastroenterol; 2021 Apr; 56(4):350-359. PubMed ID: 33582864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological analysis of 67 cases of esophageal neuroendocrine carcinoma and the effect of postoperative adjuvant therapy on prognosis.
    Liu S; Ge X; Gao Z; Zhou Q; Shi Y; Jiang W; Yang M; Sun X
    Medicine (Baltimore); 2021 Oct; 100(43):e27302. PubMed ID: 34713821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features, treatment modalities, and prognosis of esophageal neuroendocrine carcinoma: A single-center retrospective study.
    Zhang Y; Liao JT; Lin Y; Liu C; Wu ZH; Yu B; Sun S; Yu H; Hui XH; Wu XH; Zhao XM; Wang HJ; Zheng Q; Li Y; Hu ZH; Wang JL
    J Dig Dis; 2023; 24(8-9):472-479. PubMed ID: 37596865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, treatment, and survival analysis in mediastinal malignant teratoma population.
    Wang R; Li H; Jiang J; Xu G
    Transl Cancer Res; 2020 Apr; 9(4):2492-2502. PubMed ID: 35117608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Immunostaining and Tumor Markers Predict the Prognosis of Esophageal Neuroendocrine Cell Carcinoma Patients.
    Sohda M; Saeki H; Kuwano H; Miyazaki T; Yokobori T; Sano A; Sakai M; Kakeji Y; Toh Y; Doki Y; Matsubara H
    Ann Surg Oncol; 2021 Nov; 28(12):7983-7989. PubMed ID: 33843025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of metastasis and prognosis of elderly esophageal squamous cell carcinoma patients in stage IVB: a population-based study.
    Qiu G; Zhang H; Wang F; Zheng Y; Wang Y
    Transl Cancer Res; 2021 Nov; 10(11):4591-4600. PubMed ID: 35116316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esophageal Neuroendocrine Carcinoma With Pathological Complete Response After Neoadjuvant Chemotherapy Followed by Robot-assisted Surgery: A Case Report.
    Hirano K; Hirohata R; Hamai Y; Yamaguchi S; Emi M; Yoshikawa T; Ohsawa M; Okada M
    Anticancer Res; 2023 Jul; 43(7):3289-3293. PubMed ID: 37351985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel nomogram predicting cancer-specific survival and overall survival in patients with primary esophageal small-cell carcinoma: A surveillance, epidemiology, and end results-based study.
    Li J; Yu H; Peng L; Li L; Wang X; Hao J; Shao N
    J Cancer Res Ther; 2021 Jul; 17(3):630-637. PubMed ID: 34269292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-stage esophageal neuroendocrine carcinoma in a patient treated with tislelizumab combined with anlotinib: a case report.
    Zhang Y; Liu X; Liang H; Liu W; Wang H; Li T
    J Int Med Res; 2023 Jul; 51(7):3000605231187942. PubMed ID: 37498227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary papillary squamous cell carcinoma: a population-based analysis of incidence, treatment, and prognosis.
    Yuan Q; Sun N; Meng Z; Chen X
    J Thorac Dis; 2019 Oct; 11(10):4271-4281. PubMed ID: 31737312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological characteristics and survival outcomes of bladder neuroendocrine carcinomas: a population-based study.
    Niu Q; Lu Y; Xu S; Shi Q; Guo B; Guo Z; Huang T; Wu Y; Yu J
    Cancer Manag Res; 2018; 10():4479-4489. PubMed ID: 30349380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant radiotherapy for patients with pathologic node-negative esophageal carcinoma: A population based propensity matching analysis.
    Gao HJ; Shang XB; Gong L; Zhang HD; Ren P; Shi GD; Wei YC; Yu ZT
    Thorac Cancer; 2020 Feb; 11(2):243-252. PubMed ID: 31828980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based analysis of esophageal large cell neuroendocrine carcinoma between 2004 and 2015.
    Yuan G; Zhan C; Zhu D; Xie H; Wei T; Lu T; Yang Y; Zhu Y; Wang Q
    J Thorac Dis; 2019 Dec; 11(12):5480-5488. PubMed ID: 32030267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THE PROGNOSIS OF THE DIFFERENT ESOPHAGEAL NEUROENDOCRINE CARCINOMA SUBTYPES: A POPULATION-BASED STUDY.
    Tustumi F; Marques SSB; Barros EF; Henriques AC; Waisberg J; Dias AR
    Arq Gastroenterol; 2022; 59(1):53-57. PubMed ID: 35442337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastasis Patterns and Prognosis of Elderly Patients With Esophageal Adenocarcinoma in Stage IVB: A Population-Based Study.
    Qiu G; Zhang H; Wang F; Zheng Y; Wang Z; Wang Y
    Front Oncol; 2021; 11():625720. PubMed ID: 34123784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and treatment comparison in small cell neuroendocrine carcinoma of the uterine cervix based on population analyses.
    Lin LM; Lin Q; Liu J; Chu KX; Huang YX; Zhang ZK; Li T; Dai YQ; Li JL
    Cancer Med; 2020 Sep; 9(18):6524-6532. PubMed ID: 32705800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.